Mexico’s healthcare system faces a challenge that’s hard to ignore. With only 4,000 radiologists serving over 120 million people, the country has fewer than three specialists per 100,000 inhabitants—one of the lowest rates in Latin America. In states like Chiapas and Oaxaca, that ratio drops to roughly one radiologist per 100,000 people.
This is not a number. It means a late diagnosis. Such delays mean patients are waiting weeks for results that should take days. “It means conditions like diabetes and hypertension are not picked up until complications develop.
But something remarkable is going on. Mexican entrepreneurs, international health-tech companies and research institutions are using artificial intelligence to close that gap. The AI-powered diagnostic market in Mexico will increase from around $56 million to almost $594 million by 2030, Grand View Research reported. Other forecasts have the market reaching $3.27 billion by 2031.
That’s explosive growth. And it’s being driven by platforms that are actually addressing Mexico’s specific healthcare realities—not just importing solutions designed for other markets.
Here are ten AI-powered diagnostic platforms making real impact in Mexico right now.
1. Medsi AI
Medsi AI could be one of the most important Mexican health-tech stories in recent years. The Mexico City-based company has created a platform that can turn any smartphone into a medical-grade diagnostic device—no extra hardware needed.
Here’s the deal. Medsi AI records a 70-second video using a phone’s camera to capture changes in blood flow via remote photoplethysmography (rPPG). The system takes over 6,300 optical data points from that video and then processes them through proprietary machine learning algorithms to produce more than 20 health biomarkers with medical-grade precision. This includes blood pressure, heart rate, respiratory rate, hemoglobin levels (including A1C) and stress indicators.
The platform’s primary focus is early detection of chronic conditions. In Mexico, one in two people with diabetes doesn’t know they have it. Medsi AI’s predictive models can identify risk factors for diabetes, hypertension and cardiovascular conditions months or even years before symptoms appear in traditional clinical settings.
What’s special about Medsi AI is that it has a regulatory milestone. It was the first Class II Software as a Medical Device (SaMD) to be approved by COFEPRIS in the Western Hemisphere. The approval certifies the health information it generates meets medical-grade accuracy standards.
The company raised $3 million in seed capital, led by Laboratorios Sanfer, the largest private pharmaceutical company in Mexico, with participation from global funds CDPQ and General Atlantic. The support demonstrates the high level of confidence in Medsi AI’s strategy to bring preventive care to consumers through devices they already have.
Official Website: https://medsi.ai
2. Aquila+ by IMEXHS
Aquila+ seeks to address one of the most important diagnostic bottlenecks in Mexico: radiology. Aquila+ addresses a country with a dire need for radiologists with a cloud-native platform that leverages AI to speed up the diagnostics workflow and improve access to specialized care.
The platform has assistive AI built to augment, not replace, the work of radiologists. It can read complex studies, like a chest CT scan, in under 700 milliseconds, so that interpretation can be provided in real time from remote locations. Minutes count when you are dealing with critical cases, so speed is paramount.
Aquila+ was developed to meet four specific operational realities in Mexico: tele-radiology centers without capital expenditure, outpatient imaging centers without hospital information systems, hospitals requiring integration with existing PACS systems and multi-site clinic networks requiring unified protocols. It supports DICOM/HL7/FHIR integration so it can work with existing systems, rather than forcing a replacement.
Aquila+ is from IMEXHS, which has implemented more than 580 platforms in 17 countries, handling over 8.5 million studies per year. The company is certified with ISO 27001:2022 for information security and offers technical support 24/7.
The Mexican tele-radiology market was valued at $155 million in 2023 and is projected to reach $869.8 million by 2030, growing at a CAGR of close to 28%. Aquila+ is right in the middle of that expansion.
Official Website: https://www.imexhs.com
3. Amphora Health
Amphora Health is taking a different approach. The company, based in Mexico, doesn’t focus on one diagnostic function but instead builds the data infrastructure that enables AI-powered diagnostics in the first place.
Founded in 2020 by Tec de Monterrey graduate Arturo López Pineda, Amphora Health was created to address a fundamental problem: Only around 50% of Mexican healthcare professionals use electronic health records. Many are still using Excel spreadsheets or even paper. This fragmentation makes AI nearly impossible to scale.
The company’s flagship product, Vaquita EHR, is an AI-enhanced electronic health record system designed to reduce administrative burdens while capturing complete clinical data. With the click of a button, it manages appointments, prescriptions and stores complete patient histories, including studies, images and lab results.
But the real innovation is Beluga Science. The platform aggregates and structures large quantities of clinical data according to international standards such as the OMOP Common Data Model. Researchers and clinicians can investigate epidemiological trends and treatment results without having to learn how to program.
Amphora Health has developed predictive models of complications for diabetes, one of the most important health challenges in Mexico. They are working with IMSS, Mexico’s social security institute, on joint projects on diabetes, hypertension, chronic kidney disease, cancer and infectious diseases. Its work has ranged from genomics of familial hypercholesterolemia in Mexican populations to epidemiological studies of chronic kidney disease.
For hospitals and research institutions looking to build AI capabilities from the ground up, Amphora Health provides the foundational data layer that makes everything else possible.
Official Website: https://amphora.health
4. Skye Salud
Skye Salud represents something new in Mexican healthcare: a sovereign AI platform built specifically for Mexico’s health system, with data governance designed to meet local regulatory requirements.
Formed through a partnership between KNOBLOCH Information Group—Mexico’s leading authority on pharmaceutical market data—and BEN (Brand Engagement Network), a Nasdaq-listed developer of governed AI for regulated industries, Skye Salud aims to modernize clinical workflows across a system serving over 130 million people.
The core of KNOBLOCH’s platform is its proprietary data infrastructure. KNOBLOCH audits 99% of the private pharmaceutical market in Mexico, which is about 74% of the national total. It covers about 85% of the total pharmaceutical market on the sell-out level and tracks real-time sales data from 82 institutions. KNOBLOCH also has strong ties with public institutions such as IMSS and ISSSTE, pharmacy networks and regional health authorities.
Skye Salud is developing capabilities for automated documentation, predictive alerts and population health analytics, all aimed at augmenting, not replacing, clinical judgment. First pilots are planned for early 2026.
The company is led by Dr. Richard Isaacs, former chief executive officer of The Permanente Medical Group and former chief information officer of one of the largest integrated health systems in the United States. Skye Salud is not a technology play; it’s a healthcare transformation initiative and that kind of clinical leadership signals it.
The Mexican EHR/EMR market is estimated at $2.4 billion** and is expected to reach **$5.3 billion by the year 2031, at a CAGR of nearly 14%. “Skye Salud’s sovereign approach positions it well to capture a significant share of that growth.”
Official Website: https://www.skyeinteligencia.com
5. accelRare by Sanofi
Not every AI diagnostic platform has to be a commercial enterprise. Sanofi has developed a free tool, accelRare, with the help of Medical Intelligence Service, to help physicians pre-diagnose rare diseases that normally take five to 10 years or longer to diagnose.
There are an estimated 8 million people living with a rare disease in Mexico. The diagnostic odyssey is brutal for these patients: years of uncertainty, many specialists and many tests, all while their condition might be getting worse.
With AI, accelRare analyzes patient symptoms and identifies potential matches with 270 treatable rare diseases. The platform delivers results in 5 to 10 minutes, with 89% reliability.
Since the platform’s launch in mid-2025, about 400 healthcare professionals in Mexico have completed pre-diagnostic questionnaires, with a user satisfaction of 4.61 out of 5. Sanofi has trained more than 34,000 healthcare professionals across 58 medical specialties on how to use the platform. International results show that it can increase diagnostic suspicion rates by 53-93%.
For physicians who suspect a patient might have a rare disease but don’t know where to start, accelRare offers a structured, evidence-based path forward. And it’s completely free.
Official Website: https://www.accelrare.com
6. Medesk
Medesk is a clinical management platform with AI diagnostic support built right into the workflow—a major differentiator in a market where many AI tools are standalone apps.
The platform integrates electronic health records, appointment scheduling, electronic invoicing (CFDI), digital prescriptions and clinical reports in a single environment. Its EHR organizes consultation information according to the SOAP structure, using customizable templates by specialty to ensure consistent, auditable documentation that complies with NOM-024 standards.
Medesk includes AI capabilities to support diagnosis, such as building differential diagnoses, checking for drug interactions and documenting clinical care. The platform is designed to meet Mexican regulatory requirements, including NOM-024 for electronic health records and integration of CFDI with SAT for billing.
Medesk is a good fit for private practices and clinics that want AI support without the hassle of dozens of different tools. When diagnostic AI runs in the same system as scheduling, billing and records, the friction of switching between platforms disappears—and with it, some of the data security risks that come from moving patient information across unregulated tools.
Official Website: https://www.medesk.net
7. OpenEvidence
Mexican doctors facing uncertainty in diagnosis can access medical knowledge powered by AI with OpenEvidence, a free access point. Verified doctors can register for free.
The platform helps physicians answer clinical questions with evidence-based information, keeping them up-to-date with the medical literature and the latest research to inform their diagnostic reasoning. Tools like OpenEvidence can help level the playing field for independent practitioners in Mexico, who often don’t have the institutional resources of their hospital-based peers.
OpenEvidence is not a diagnostic platform in the traditional sense, but it can be used as a clinical decision support tool to inform diagnostic thinking. “It’s especially useful for primary care physicians who see such a broad spectrum of conditions and need reliable, up-to-date information at the point of care.”
LinkedIn: https://www.openevidence.com
8. Doctoranytime
Doctoranytime has evolved from a simple appointment booking platform to something much more sophisticated, with AI components integrated into its telemedicine capabilities. The platform connects patients with healthcare providers throughout Mexico, using AI to improve triage, match patients with appropriate specialists and streamline clinical documentation.
Doctoranytime is the digital front door to the healthcare system for patients in Mexico City, Guadalajara, or Monterrey needing quick access to care. AI integration helps with the triage of cases—directing urgent situations to immediate care and routine concerns to scheduled appointments.
Official Website: https://www.doctoranytime.mx
9. Sofía Salud
Sofía Salud is another Mexican telemedicine platform that has incorporated AI into its diagnostic and triage flows. The platform offers virtual consultations with healthcare professionals and employs AI to assist with symptom assessment and care coordination.
Sofía Salud is a scalable option for employers looking to provide healthcare access for employees all over Mexico, combining human clinical expertise with AI-driven efficiency. The platform is especially active in corporate wellness programs and insurance partnerships.
LinkedIn: https://www.sofiasalud.com
10. 1DOC3
1DOC3 brings AI-enhanced telehealth to Spanish-speaking patients across Latin America, including Mexico. The platform offers virtual consultations, symptom checking and health education—all delivered in Spanish and tailored to regional health concerns.
What’s special about 1DOC3 is its focus on accessibility. The platform is designed for users who may not be comfortable with digital health tools. It has a communication style and interface that is approachable, rather than clinical. AI helps with initial triage and health guidance and physicians do the consultation and treatment decisions.
Official Website: https://www.1doc3.com
What to Consider Before Adopting AI Diagnostics in Your Practice
The platforms above represent real progress. But responsible adoption matters. Here are the key factors to evaluate.
Regulatory Compliance
In Mexico, COFEPRIS is the regulatory authority for medical devices and software. Medsi AI’s Class II SaMD approval sets a benchmark—it means the platform meets medical-grade accuracy standards validated by the regulator. For platforms without that approval, the evidence base may be less rigorous.
Data Privacy
The Federal Law on Protection of Personal Data Held by Private Parties (LFPDPPP) protects patient data in Mexico. Any AI diagnostic platform must have explicit protocols for data handling, storage and security. Platforms like Skye Salud and Medesk stress that they adhere to Mexican data protection laws.
The Hallucination Problem
Many diagnostic support tools are based on large language models (LLMs). These are able to generate plausible but false information with the same conviction as correct information. In a clinical setting, hallucinations could translate to a wrong dosage recommendation, a missed drug interaction, or a differential diagnosis that does not exist in the medical literature.
This risk isn’t a reason to avoid AI entirely. It’s a reason to use AI as decision support, not decision replacement. The physician remains the final authority.
Latin American Data Gaps
The vast majority of current AI diagnostic models predominantly rely on literature and data from high-income countries and in English. Their performance in Mexican patient populations with different disease prevalence and clinical presentation may be lower than reported studies suggest. Platforms are addressing this gap head-on by bringing in local data, such as what Amphora Health is doing with IMSS.
The Road Ahead
The AI diagnostics landscape in Mexico is changing fast. Market projections are anywhere from $56 million to possibly billions in a decade, which is real momentum. But the numbers are less important than what they represent: faster diagnoses, broader access and better outcomes for patients who wait too long for answers today.
These platforms are not experiments in science. Today, Mexican physicians and healthcare institutions deploy these tools. They’re tackling real problems—radiologist shortages, undiagnosed chronic conditions and siloed data systems—with solutions customized to Mexico’s unique context.
For healthcare providers considering adoption, the way forward is pragmatic: begin with high-impact use cases, measure outcomes rigorously and scale what works. The technology is there. The question is how fast the system can absorb it.
FAQ
What is an AI-powered diagnostic platform?
An AI-based diagnostic platform leverages artificial intelligence technologies like machine learning, computer vision and natural language processing to help healthcare professionals diagnose diseases, interpret medical images, analyze patient data, or predict health risks. These tools assist with clinical decision-making but do not replace physician judgment.
Are AI diagnostic tools approved for use in Mexico?
In Mexico, COFEPRIS regulates medical devices and software. Some platforms, such as Medsi AI, have received Class II SaMD approval, meaning they have medical-grade accuracy. Other platforms may not have formal regulatory approval and should be carefully evaluated prior to clinical use.
Can AI diagnostic platforms replace doctors in Mexico?
Nah. All the platforms profiled here are meant as decision support, not replacements. AI is able to crunch data faster and spot patterns a human may not see, but clinical judgment, patient context and accountability remain with the licensed physician.
How accurate are AI diagnostic tools?
Accuracy varies greatly with the platform and use case. accelRare: 89% reliability in pre-diagnosis of rare diseases. Medsi AI delivers the accuracy of medical-grade vital sign readings. Aquila+ offers real-time interpretation of radiology. Always encouraged is independent verification of accuracy.
What’s the biggest challenge for AI diagnostics in Mexico?
Training data gaps are a major issue. Most AI models were trained on English-language data from high-income countries, which may not perform as well on Mexican patient populations with different disease prevalences and clinical presentations.
Do I need special hardware to use AI diagnostic platforms?
Well, it depends on the platform. Medsi AI works on any smartphone camera; no additional hardware is required. Aquila+ is a cloud-based solution that connects to existing imaging systems. Amphora Health’s Vaquita EHR is available for standard computers and mobile devices.
Are there free AI diagnostic tools available for Mexican physicians?
Yes, AccelRare is free to physicians pre-diagnosing rare diseases. OpenEvidence allows verified doctors to sign up for free. Amphora Health has a free version of its Vaquita EHR with powerful functionality.
How do AI diagnostic platforms handle patient data privacy?
Reputable sites are compliant with Mexico’s LFPDPPP and use security protocols such as encryption, control of access and audit trails. Regulatory compliance and data protection are explicit requirements built into the Medesk and Skye Salud architecture.
Can AI diagnostic tools help with Mexico’s radiologist shortage?
Yes. Aquila+ can evaluate complex imaging studies in less than 700 milliseconds, allowing interpretation from anywhere and access to specialist expertise in underserved regions. AI doesn’t solve the shortage, but it does help radiologists be more efficient and serve more patients.
What should I look for when choosing an AI diagnostic platform?
Prioritize regulatory status (COFEPRIS approval if applicable), data privacy compliance, clinical validation evidence, integration with your existing systems and whether the platform was designed for or adapted to Mexican patient populations.
